Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MK0653 When Added to Current Regimen in Patients With Homozygous Sitosterolemia
Conditions
Interventions
MK0653, ezetimibe
Comparator: placebo
Start Date
February 12, 2001
Primary Completion Date
September 18, 2001
Completion Date
November 30, 2004
Last Updated
August 15, 2024
NCT06690151
NCT05647213
NCT07462260
NCT07057466
NCT04843371
NCT06400004
Lead Sponsor
Organon and Co
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions